Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autophagy01:27

Autophagy

5.0K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

7.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.6K
Autophagic Cell Death01:18

Autophagic Cell Death

3.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.3K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

99
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
99
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

800
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
800

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early postnatal changes in serum creatinine from birth to peak and subsequent decline in preterm neonates.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates.

Frontiers in aging neuroscience·2024
Same author

Isolation of Shiga Toxin-Producing Escherichia coli from the Surfaces of Beef Carcasses in Slaughterhouses in Japan.

Journal of food protection·2024
Same author

Relationship between the serum creatinine concentrations of preterm neonates within 24 h of birth and their mothers before delivery.

Clinical and experimental nephrology·2023
Same author

Anomalous Dependence of Translational Diffusion on the Water Mole Fraction for Solute Molecules Dissolved in a 1-Butyl-3-methylimidazolium Tetrafluoroborate/Water Mixture.

The journal of physical chemistry. B·2023
Same author

High-fat diet-induced activation of SGK1 promotes Alzheimer's disease-associated tau pathology.

Human molecular genetics·2021

Related Experiment Video

Updated: May 1, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

1.4K

Lithium and autophagy.

Yumiko Motoi1, Kohei Shimada1, Koichi Ishiguro1

  • 1†Department of Diagnosis, Prevention and Treatment of Dementia, ‡Department of Neurology, and §Department of Pharmacy, Juntendo University School of Medicine, Tokyo 113-8421, Japan.

ACS Chemical Neuroscience
|April 18, 2014
PubMed
Summary

Lithium enhances autophagy, aiding the degradation of harmful proteins and damaged mitochondria, potentially benefiting patients with neuropsychiatric disorders like bipolar disorder.

Keywords:
GSK3β, IMPaseHuntingtinLithiumautophagyprion proteintauα-synuclein

More Related Videos

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
11:39

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Published on: July 21, 2017

33.9K
Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
06:58

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles

Published on: October 18, 2024

1.3K

Related Experiment Videos

Last Updated: May 1, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

1.4K
Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
11:39

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Published on: July 21, 2017

33.9K
Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
06:58

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles

Published on: October 18, 2024

1.3K

Area of Science:

  • Neuropharmacology
  • Cellular Biology
  • Neuroscience

Background:

  • Lithium is a mood stabilizer for bipolar disorder.
  • Lithium exhibits neuroprotective effects through various mechanisms, including autophagy regulation.
  • Autophagy plays a crucial role in cellular homeostasis and disease pathogenesis.

Purpose of the Study:

  • To explore lithium's role in modulating autophagy in neuropsychiatric conditions.
  • To elucidate the signaling pathways involved in lithium-induced autophagy.
  • To assess the therapeutic potential of lithium's autophagy-enhancing properties.

Main Methods:

  • Literature review of studies on lithium, autophagy, and neuropsychiatric disorders.
  • Analysis of lithium's effects on protein aggregate degradation and mitophagy.
  • Investigation of mammalian target of rapamycin (mTOR)-dependent and -independent pathways.

Main Results:

  • Lithium enhances the degradation of aggregate-prone proteins (mutant huntingtin, tau, alpha-synuclein) and damaged mitochondria in neurodegenerative disease models.
  • Conflicting observations exist, with some models showing lithium-induced autophagy downregulation (cerebral ischemia, Alzheimer's disease).
  • Lithium's autophagy modulation may involve both mTOR-independent (IP3 pathway in Huntington's and Parkinson's) and mTOR-dependent (GSK3β inhibition) pathways.

Conclusions:

  • Lithium's ability to regulate autophagy is a key neuroprotective mechanism.
  • The specific pathway (mTOR-dependent or -independent) may vary depending on the neuropsychiatric condition.
  • Targeting lithium-induced autophagy offers a promising therapeutic strategy for neuropsychiatric disorders.